Non‐bacterial cystitis with increased expression of programmed death‐ligand 1 in the urothelium: An unusual immune‐related adverse event during treatment with pembrolizumab for lung adenocarcinoma-Reference-Cited by-同舟云学术

Non‐bacterial cystitis with increased expression of programmed death‐ligand 1 in the urothelium: An unusual immune‐related adverse event during treatment with pembrolizumab for lung adenocarcinoma

Published:2020-08-12 Issue:6 Volume:3 Page:266-269
ISSN:2577-171X
Container-title:IJU Case Reports
language:en
Short-container-title:IJU Case Reports

Author:

Ueki Yohei¹,Matsuki Masahiro¹,Kubo Terufumi²^ORCID,Morita Rena²,Hirohashi Yoshihiko²,Sato Syunsuke¹,Horibe Ryota³,Matsuo Kazuhiko⁴,Tsukahara Tomohide²,Kanaseki Takayuki²,Takakuwa Yasunari⁵,Satoh Masaaki⁵,Itoh Naoki¹,Torigoe Toshihiko²

Affiliation:

1. Department of Urology NTT‐East Corporation Sapporo Medical CenterSapporo Japan

2. Department of Pathology School of Medicine Sapporo Medical UniversitySapporo Japan

3. Department of Respiratory Medicine NTT‐East Corporation Sapporo Medical CenterSapporo Japan

4. Sapporo Clinical Laboratory Inc. Sapporo Japan

5. Department of Clinical Pathology NTT‐East Corporation Sapporo Medical Center Sapporo Hokkaido Japan

Publisher

Wiley

Subject

Linguistics and Language,Anthropology,History,Language and Linguistics,Cultural Studies

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iju5.12211

Reference6 articles.

2. Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab

4. Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

5. Two cases of nonbacterial cystitis associated with nivolumab, the anti-programmed-death-receptor-1 inhibitor

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case reports of immune-related cystitis and the antibody combination hypothesis;Immunotherapy;2024-09-12

2. Non-bacterial cystitis caused by pembrolizumab therapy for adenocarcinoma of the lung: a case report;Frontiers in Immunology;2024-07-05

3. Acute Non-infectious Cystitis Secondary to Immune-Related Adverse Events in a Patient Receiving Pembrolizumab for Treatment of Non-small Cell Lung Cancer: A Case Report;Cureus;2024-03-06

5. Recurrent Cystitis Associated With 2 Programmed Death 1 Inhibitors;Journal of Immunotherapy;2023-09-18